Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1965 Sep;41(479):526–535. doi: 10.1136/pgmj.41.479.526

Clinical experiences with propranolol.

E M Besterman, D H Friedlander
PMCID: PMC2483053  PMID: 5827672

Full text

PDF
527

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNETT A. J., BRANDSTATER M. E. PRONETHALOL ("ALDERLIN") A BETA ADRENERGIC INHIBITOR: PHARMACOLOGICAL OBSERVATIONS AND TRIAL IN ANGINA PECTORIS. Med J Aust. 1964 May 9;1:714–716. doi: 10.5694/j.1326-5377.1964.tb114196.x. [DOI] [PubMed] [Google Scholar]
  2. BLACK J. W., CROWTHER A. F., SHANKS R. G., SMITH L. H., DORNHORST A. C. A NEW ADRENERGIC BETARECEPTOR ANTAGONIST. Lancet. 1964 May 16;1(7342):1080–1081. doi: 10.1016/s0140-6736(64)91275-9. [DOI] [PubMed] [Google Scholar]
  3. DACK S., ROBBIN S. R. Treatment of heart block and Adams-Stokes syndrome with sustained-action isoproterenol. JAMA. 1961 May 13;176:505–512. doi: 10.1001/jama.1961.03040190027008. [DOI] [PubMed] [Google Scholar]
  4. DOLE V. P. A relation between non-esterified fatty acids in plasma and the metabolism of glucose. J Clin Invest. 1956 Feb;35(2):150–154. doi: 10.1172/JCI103259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DORNHORST A. C., LAURENCE D. R. USE OF PRONETHALOL IN PHAEOCHROME TUMOURS. Br Med J. 1963 Nov 16;2(5367):1250–1251. doi: 10.1136/bmj.2.5367.1250. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. DORNHORST A. C., ROBINSON B. F. Clinical pharmacology of a beta-adrenergic-blocking agent (Nethalide). Lancet. 1962 Aug 18;2(7251):314–316. doi: 10.1016/s0140-6736(62)90104-6. [DOI] [PubMed] [Google Scholar]
  7. FLEMING H. A., MIRAMS J. A. A clinical trial of a sustained-action preparation of isoprenaline in the treatment of heartblock. Lancet. 1963 Aug 3;2(7301):214–217. doi: 10.1016/s0140-6736(63)90114-4. [DOI] [PubMed] [Google Scholar]
  8. HAMER J., GRANDJEAN T., MELENDEZ L., SOWTON G. E. EFFECT OF PROPRANOLOL (INDERAL) IN ANGINA PECTORIS: PRELIMINARY REPORT. Br Med J. 1964 Sep 19;2(5411):720–723. doi: 10.1136/bmj.2.5411.720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HERRING A. B. ACTION OF PRONETHALOL ON PARKINSONIAN TREMOR. Lancet. 1964 Oct 24;2(7365):892–892. doi: 10.1016/s0140-6736(64)90746-9. [DOI] [PubMed] [Google Scholar]
  10. LOWN B., AMARASINGHAM R., NEUMAN J. New method for terminating cardiac arrhythmias. Use of synchronized capacitor discharge. JAMA. 1962 Nov 3;182:548–555. [PubMed] [Google Scholar]
  11. MARSH W. H., FINGERHUT B., KIRSCH E. Adaptation of an alkaline phosphatase method for automatic colorimetric analysis. Clin Chem. 1959 Apr;5(2):119–126. [PubMed] [Google Scholar]
  12. MCDONALD L., RESNEKOV L., O'BRIEN K. DIRECT-CURRENT SHOCK IN TREATMENT OF DRUG-RESISTANT CARDIAC ARRHYTHMIAS. Br Med J. 1964 Jun 6;1(5396):1468–1470. doi: 10.1136/bmj.1.5396.1468. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. MCNEILL R. S. EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS. Lancet. 1964 Nov 21;2(7369):1101–1102. doi: 10.1016/s0140-6736(64)92617-0. [DOI] [PubMed] [Google Scholar]
  14. ORAM S., DAVIES J. P. FURTHER EXPERIENCE OF ELECTRICAL CONVERSION OF ATRIAL FIBRILLATION TO SINUS RHYTHM: ANALYSIS OF 100 PATIENTS. Lancet. 1964 Jun 13;1(7346):1294–1298. doi: 10.1016/s0140-6736(64)91692-7. [DOI] [PubMed] [Google Scholar]
  15. PAGET G. E. CARCINOGENIC ACTION OF PRONETHALOL. Br Med J. 1963 Nov 16;2(5367):1266–1267. doi: 10.1136/bmj.2.5367.1266-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. PATON D. M. BETA RECEPTOR BLOCKADE IN THE DIAGNOSIS OF PHAEOCHROMOCYTOMA. Lancet. 1964 Nov 21;2(7369):1125–1125. doi: 10.1016/s0140-6736(64)92652-2. [DOI] [PubMed] [Google Scholar]
  17. PAYNE J. P., SENFIELD R. M. PRONETHALOL IN TREATMENT OF VENTRICULAR ARRHYTHMIAS DURING ANAESTHESIA. Br Med J. 1964 Mar 7;1(5383):603–604. doi: 10.1136/bmj.1.5383.603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. PILKINGTON T. R., LOWE R. D., ROBINSON B. F., TITTERINGTON E. Effect of adrenergic blockade on glucose and fatty-acid mobilisation in man. Lancet. 1962 Aug 18;2(7251):316–317. doi: 10.1016/s0140-6736(62)90105-8. [DOI] [PubMed] [Google Scholar]
  19. PRICHARD B. N., DICKINSON C. J., ALLEYNE G. A., HURST P., HILL I. D., ROSENHEIM M. L., LAURENCE D. R. EFFECT OF PRONETHALOL IN ANGINA PECTORIS. Br Med J. 1963 Nov 16;2(5367):1226–1229. doi: 10.1136/bmj.2.5367.1226. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. PRICHARD B. N., GILLAM P. M. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. doi: 10.1136/bmj.2.5411.725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. PRICHARD B. N. HYPOTENSIVE ACTION OF PRONETHALOL. Br Med J. 1964 May 9;1(5392):1227–1228. doi: 10.1136/bmj.1.5392.1227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. SRIVASTAVA S. C., DEWAR H. A., NEWELL D. J. DOUBLE-BLIND TRIAL OF PROPRANOLOL (INDERAL) IN ANGINA OF EFFORT. Br Med J. 1964 Sep 19;2(5411):724–725. doi: 10.1136/bmj.2.5411.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. STOCK J. P., DALE N. BETA-ADRENERGIC RECEPTOR BLOCKADE IN CARDIAC ARRHYTHMIAS. Br Med J. 1963 Nov 16;2(5367):1230–1233. doi: 10.1136/bmj.2.5367.1230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. TSOLAKAS T. C., DAVIES J. P., ORAM S. PROPRANOLOL IN ATTEMPTED MAINTENANCE OF SINUS RHYTHM AFTER ELECTRICAL DEFIBRILLATION. Lancet. 1964 Nov 14;2(7368):1064–1064. doi: 10.1016/s0140-6736(64)91020-7. [DOI] [PubMed] [Google Scholar]
  25. VAN HANDEL E., ZILVERSMIT D. B. Micromethod for the direct determination of serum triglycerides. J Lab Clin Med. 1957 Jul;50(1):152–157. [PubMed] [Google Scholar]
  26. WROBLEWSKI F., LADUE J. S. Serum glutamic oxalacetic transaminase activity as an index of liver cell injury: a preliminary report. Ann Intern Med. 1955 Aug;43(2):345–360. doi: 10.7326/0003-4819-43-2-345. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES